Faculty of Medicine, Health and Human Sciences, Macquarie University, F10A, 2 Technology Place, North Ryde, NSW, 2109, Australia.
School of Medicine, Deakin University, Melbourne, VIC, Australia.
Cell Mol Life Sci. 2022 Mar 4;79(3):172. doi: 10.1007/s00018-022-04185-6.
Neuroserpin is an axonally secreted serpin that is involved in regulating plasminogen and its enzyme activators, such as tissue plasminogen activator (tPA). The protein has been increasingly shown to play key roles in neuronal development, plasticity, maturation and synaptic refinement. The proteinase inhibitor may function both independently and through tPA-dependent mechanisms. Herein, we discuss the recent evidence regarding the role of neuroserpin in healthy and diseased conditions and highlight the participation of the serpin in various cellular signalling pathways. Several polymorphisms and mutations have also been identified in the protein that may affect the serpin conformation, leading to polymer formation and its intracellular accumulation. The current understanding of the involvement of neuroserpin in Alzheimer's disease, cancer, glaucoma, stroke, neuropsychiatric disorders and familial encephalopathy with neuroserpin inclusion bodies (FENIB) is presented. To truly understand the detrimental consequences of neuroserpin dysfunction and the effective therapeutic targeting of this molecule in pathological conditions, a cross-disciplinary understanding of neuroserpin alterations and its cellular signaling networks is essential.
神经丝氨酸蛋白酶抑制剂是一种轴突分泌的丝氨酸蛋白酶抑制剂,参与调节纤溶酶原及其酶激活剂,如组织型纤溶酶原激活物(tPA)。该蛋白在神经元发育、可塑性、成熟和突触细化中起着关键作用。蛋白酶抑制剂可能通过独立和 tPA 依赖的机制发挥作用。本文讨论了神经丝氨酸蛋白酶抑制剂在健康和疾病状态下的作用的最新证据,并强调了该丝氨酸蛋白酶抑制剂在各种细胞信号通路中的参与。该蛋白中也已鉴定出几种多态性和突变,这些突变可能会影响丝氨酸蛋白酶抑制剂的构象,导致聚合物的形成及其在细胞内的积累。目前已经了解了神经丝氨酸蛋白酶抑制剂在阿尔茨海默病、癌症、青光眼、中风、神经精神疾病和伴有神经丝氨酸蛋白酶抑制剂包涵体的家族性脑病(FENIB)中的作用。为了真正了解神经丝氨酸蛋白酶抑制剂功能障碍的有害后果以及在病理条件下对该分子的有效治疗靶向,需要跨学科了解神经丝氨酸蛋白酶抑制剂的改变及其细胞信号网络。